Cargando…
MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma
BACKGROUND: Minichromosome maintenance complex component 6 (MCM6), as an important replication permission factor, is involved in the pathogenesis of various tumors. Here we studied the expression of MCM6 in neuroblastoma and its influence on tumor characteristics and prognosis. METHODS: Publicly ava...
Autores principales: | Gu, Yaoyao, Hu, Xiaoxiao, Liu, Xiaowei, Cheng, Cheng, Chen, Kai, Wu, Yeming, Wu, Zhixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262023/ https://www.ncbi.nlm.nih.gov/pubmed/34233647 http://dx.doi.org/10.1186/s12885-021-08344-z |
Ejemplares similares
-
PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis
por: Liu, Xiaowei, et al.
Publicado: (2022) -
MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression
por: Liu, Zhikun, et al.
Publicado: (2018) -
XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor
por: Pan, Lijia, et al.
Publicado: (2021) -
P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma
por: Cheng, Cheng, et al.
Publicado: (2023) -
Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway
por: Cai, Yuanxia, et al.
Publicado: (2020)